It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Visual impairment is common in people living with dementia and regular ophthalmological exams may improve their quality of life. We evaluated visual function in a cohort of elderly individuals and analyzed its association with their degree of cognitive impairment. Participants underwent neurological and neuropsychological exams, neuro-ophthalmological assessment (visual acuity, intraocular pressure, rates of past ophthalmological pathologies, use of ocular correction, treatments and surgeries) and optical coherence tomography (OCT) scan. We analyzed differences in ophthalmological characteristics among diagnostic groups. The final sample of 1746 study participants aged ≥ 50 comprised 229 individuals with Subjective Cognitive Decline (SCD), 695 with mild cognitive impairment (MCI) and 833 with Dementia (Alzheimer disease: n = 660; vascular dementia: n = 92, Lewy body dementia: n = 34; frontotemporal dementia: n = 19 and other: n = 28). Age, gender and education were used as covariates. Patients with Dementia, compared to those with SCD and MCI, presented worse visual acuity (p < 0.001), used less visual correction (p = 0.02 and p < 0.001, respectively) and fewer ophthalmological treatments (p = 0.004 and p < 0.001, respectively) and underwent fewer ocular surgeries (p = 0.009 and p < 0.001, respectively). OCT image quality worsened in parallel to cognitive decline (Dementia vs SCD: p = 0.008; Dementia vs MCI: p < 0.001). No group differences in past ophthalmological disorders or abnormal OCT findings were detected. Efforts should be made to ensure dementia patients undergo regular ophthalmological assessments to correct their visual function in order to improve their quality of life.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Castilla-Martí, Miguel 2
; Valero, Sergi 3 ; Martínez, Joan 1 ; Sánchez, Domingo 1 ; Hernández, Isabel 3 ; Rosende-Roca, Maitée 1 ; Vargas, Liliana 1 ; Mauleón, Ana 1 ; Rodríguez-Gómez, Octavio 1 ; Abdelnour, Carla 1 ; Gil, Silvia 1 ; Santos-Santos, Miguel A 1
; Alegret, Montserrat 3 ; Espinosa, Ana 3 ; Ortega, Gemma 3 ; Pérez-Cordón, Alba 1 ; Sanabria, Ángela 3 ; Roberto, Natalia 1 ; Moreno-Grau, Sonia 1 ; de Rojas, Itziar 1 ; Simó, Rafael 4 ; Ciudin, Andreea 4 ; Hernández, Cristina 4 ; Orellana, Adelina 1 ; Monté-Rubio, Gemma 1 ; Benaque, Alba 1 ; Ruiz, Agustín 3 ; Tárraga, Lluís 3 ; Boada, Mercè 3 1 Alzheimer Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Barcelona, Spain
2 Clínica Oftalmológica Dr. Castilla, Barcelona, Spain; Department of Ophthalmology, Hospital del Mar and Hospital de l’Esperança - Parc de Salut Mar, Barcelona, Spain
3 Alzheimer Research Center and Memory Clinic, Fundació ACE Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya (UIC), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain
4 Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain; Institut de Recerca Vall d’Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), Barcelona, Spain




